Endoscopic Ultrasound‐Guided Bypass Reversal for Postprandial Reactive Hypoglycaemia After Roux‐En‐Y Gastric Bypass Surgery: Results of a Prospective Pilot Study

BACKGROUND AND AIM: Postprandial reactive hypoglycaemia syndrome (PRHS) is an increasingly recognized complication after Roux-en-Y gastric bypass (RYGB) surgery. We investigated whether endoscopic ultrasound (EUS)-guided bypass reversal could provide a minimally invasive alternative to surgery in patients with severe, therapy-refractory PRHS. METHODS: We conducted a prospective pilot study in 12 patients with severe, therapy-refractory PRHS after RYGB. A 20 × 10 mm lumen-apposing metal stent (LAMS) was placed between the gastric pouch and excluded stomach. Patients were followed for 6 months with four visits and a mixed-meal test at 6 months. Primary outcomes were immediate and sustained clinical response. Secondary outcomes included technical success, quality of life assessed using a visual analogue scale (VAS), adverse events and weight change. RESULTS: Technical success was achieved in all patients. Immediate clinical response occurred in 10/12 patients (83.3%). Sustained response was observed in 7/10 patients with 6-month follow-up (70.0%; 7/8 responders). At 6 months, median VAS increased by 5.0 points (97.85% CI: 0.0-8.0) in all patients and by 6.0 points (99.22% CI: 2.0-8.0) in responders. Adverse events occurred in 2/10 patients and were moderate. One patient developed gastric discomfort and reflux; another experienced stent migration with loss of response, restored after endoscopic repositioning and fixation. Mean weight change at 6 months was -0.3 kg (95% CI: -3.89 to 3.29). CONCLUSION: In this prospective pilot study, EUS-guided gastric bypass reversal was feasible, appeared safe and was associated with a promising clinical response in severe, therapy-refractory PRHS after RYGB. Larger studies are needed to confirm these preliminary findings.

Authors

Institutions

Publication Details

Journal
Diabetes Obesity and Metabolism
Published
2026-11-16
DOI
https://doi.org/10.1111/dom.71548
Primary Topic
Bariatric Surgery and Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Endoscopic Ultrasound‐Guided Bypass Reversal for Postprandial Reactive Hypoglycaemia After Roux‐En‐Y Gastric Bypass Surgery: Results of a Prospective Pilot Study

Charlotte Verroken, Bruno Lapauw, Yves Van Nieuwenhove, Pieter Hindryckx et al.
2 links
Diabetes Obesity and Metabolism
Bariatric Surgery and Outcomes
article

Endoscopic Ultrasound‐Guided Bypass Reversal for Postprandial Reactive Hypoglycaemia After Roux‐En‐Y Gastric Bypass Surgery: Results of a Prospective Pilot Study

Charlotte Verroken, Bruno Lapauw, Yves Van Nieuwenhove, Pieter Hindryckx, Emine Gökce, E. De Muyt
article en

Abstract

BACKGROUND AND AIM: Postprandial reactive hypoglycaemia syndrome (PRHS) is an increasingly recognized complication after Roux-en-Y gastric bypass (RYGB) surgery. We investigated whether endoscopic ultrasound (EUS)-guided bypass reversal could provide a minimally invasive alternative to surgery in patients with severe, therapy-refractory PRHS. METHODS: We conducted a prospective pilot study in 12 patients with severe, therapy-refractory PRHS after RYGB. A 20 × 10 mm lumen-apposing metal stent (LAMS) was placed between the gastric pouch and excluded stomach. Patients were followed for 6 months with four visits and a mixed-meal test at 6 months. Primary outcomes were immediate and sustained clinical response. Secondary outcomes included technical success, quality of life assessed using a visual analogue scale (VAS), adverse events and weight change. RESULTS: Technical success was achieved in all patients. Immediate clinical response occurred in 10/12 patients (83.3%). Sustained response was observed in 7/10 patients with 6-month follow-up (70.0%; 7/8 responders). At 6 months, median VAS increased by 5.0 points (97.85% CI: 0.0-8.0) in all patients and by 6.0 points (99.22% CI: 2.0-8.0) in responders. Adverse events occurred in 2/10 patients and were moderate. One patient developed gastric discomfort and reflux; another experienced stent migration with loss of response, restored after endoscopic repositioning and fixation. Mean weight change at 6 months was -0.3 kg (95% CI: -3.89 to 3.29). CONCLUSION: In this prospective pilot study, EUS-guided gastric bypass reversal was feasible, appeared safe and was associated with a promising clinical response in severe, therapy-refractory PRHS after RYGB. Larger studies are needed to confirm these preliminary findings.

Diabetes Obesity and Metabolism
Ghent University Hospital (BE), Ghent University (BE)
Good health and well-being
Bariatric Surgery and Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon